Have an Emergency?

For urgent assistance, please contact emergency response services.

Call: 911

Product Questions?

Questions, comments or concerns about Rising Pharmaceuticals products? Contact one of our trusted professionals today.

Call (800) 521-5340

Compare Products

Compares to the labeled active ingredients in Reference Brand. The trademark or tradename referenced is NOT registered, owned or licensed by Rising Pharmaceuticals, Inc. or its affiliates.

Inidcated for the treatment of migraine headaches.

Zolmitriptan ODT Zolmitriptan ODT

Zolmitriptan ODT

Compare to: Zomit ZMT® Tablets*
Strength: 2.5mg | 5mg
Downloadable Documents:
PDFPackage Insert - Zolmitriptan ODT.pdf
* Zomit ZMT® Tablets are a registered trademark of Impax Laboratories Inc.
This information has been designed as a quick reference. It is intended as a reference source only and not for prescribing or dispensing product. The appropriate approved prescribing information should be consulted. Images viewed herein may appear different than they do when viewing them live because of computer and/or photographic distortion. In addition, over time, some images and information for a particular product may change. For the most up-to-date product information, please contact your pharmacist or physician.

Zolmitriptan is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use

  • Only use zolmitriptan if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan is administered to treat any subsequent attacks.
  • Zolmitriptan is not indicated for the prevention of migraine attacks.
  • Safety and effectiveness of zolmitriptan have not been established for cluster headache.